A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of retinal diseases 3.2.1.2 Rising research & development activities related to retinal biologics 3.2.1.3 Advancements in biologic therapies 3.2.2 Industry pitfalls & challenges 3.2.2.1 Stringent regulatory requirements 3.2.2.2 Risk of potential adverse effects 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Pipeline analysis 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 VEGF-A antagonist 5.3 TNF-a inhibitor Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Macular degeneration 6.3 Diabetic retinopathy 6.4 Uveitis 6.5 Other indications Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Hospital pharmacies 7.3 Retail pharmacies 7.4 Online pharmacies Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 France 8.3.4 Spain 8.3.5 Italy 8.3.6 Netherlands 8.3.7 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Australia 8.4.5 South Korea 8.4.6 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Mexico 8.5.3 Rest of Latin America 8.6 Middle East and Africa 8.6.1 South Africa 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Rest of Middle East and Africa Chapter 9 Company Profiles 9.1 AbbVie Inc. 9.2 Amgen Inc. 9.3 Janssen Pharmaceuticals (Johnson & Johnson) 9.4 F-Hoffman La Roche Ltd. 9.5 Oxurion NV 9.6 Novartis AG 9.7 MeiraGTx Limited 9.8 Regeneron Pharmaceuticals Inc. 9.9 OncoGene Pharmaceuticals 9.10 SemaThera Inc.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook